Immune checkpoint inhibitors, like PD-1 or PD-L1 inhibitors, are treatments that help the immune system recognize and attack cancer cells. Learn more here.

Compare anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) (anti-programmed cell death-1 (PD-1) monoclonal antibodies). View important safety information, ratings, user reviews, …

Immune checkpoint inhibitors are a type of immunotherapy that block immune checkpoint proteins from binding with partner proteins. Learn about the cancers treated with checkpoint inhibitors and the side …

Immune-related adverse events may be caused by checkpoint inhibitors. Altering checkpoint inhibition can have diverse effects on most organ systems of the body.

Immunotherapy is used to treat many types of cancer, and the list is growing. But immunotherapy doesn’t work for all cancers or patients yet. Here’s which patients and cancers may qualify for …

Immune checkpoint inhibitors work by blocking checkpoint proteins from binding with their partner proteins. This prevents the “off” signal from being sent, allowing the T cells to kill cancer cells.

View list of generic and brand names of drugs used for treatment of Immune Checkpoint Inhibitors for Cancer Treatment (Cancer Treatment using Immune Checkpoint Inhibitors). Find...

Dec 5, 2025 · Learn what ICIs are FDA approved, including the major classes like PD-1, PD-L1, and CTLA-4 inhibitors. Explore specific drugs like Keytruda and Opdivo and how they target cancer.

Checkpoint inhibitors are a type of immunotherapy that block different checkpoint proteins. Examples include pembrolizumab (Keytruda) and ipilimumab (Yervoy).

Dec 25, 2024 · Immune checkpoint inhibitors (ICIs) have shown great success, with FDA-approved drugs like PD-1 inhibitors (Nivolumab, Pembrolizumab, Cemiplimab), PD-L1 inhibitors (Atezolizumab, …